

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 9.08436655 |
| 2 | doxorubicin metabolic process (GO:0044598) | 9.08436655 |
| 3 | daunorubicin metabolic process (GO:0044597) | 9.08436655 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.95213215 |
| 5 | mannose metabolic process (GO:0006013) | 5.84242451 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.37177183 |
| 7 | protein localization to kinetochore (GO:0034501) | 5.29710218 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.25250419 |
| 9 | maintenance of protein location in nucleus (GO:0051457) | 5.16466250 |
| 10 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.07714936 |
| 11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.05551618 |
| 12 | coenzyme catabolic process (GO:0009109) | 4.95076016 |
| 13 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.85619220 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.84238615 |
| 15 | somite rostral/caudal axis specification (GO:0032525) | 4.84222628 |
| 16 | negative regulation of epidermis development (GO:0045683) | 4.78627731 |
| 17 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.75958455 |
| 18 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.73522894 |
| 19 | rRNA transcription (GO:0009303) | 4.71274087 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.62805175 |
| 21 | cellular modified amino acid catabolic process (GO:0042219) | 4.53001497 |
| 22 | negative regulation of telomerase activity (GO:0051974) | 4.51947468 |
| 23 | hormone catabolic process (GO:0042447) | 4.50774079 |
| 24 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.48833155 |
| 25 | regulation of response to osmotic stress (GO:0047484) | 4.45127611 |
| 26 | muscle organ morphogenesis (GO:0048644) | 4.42916462 |
| 27 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.42323652 |
| 28 | positive thymic T cell selection (GO:0045059) | 4.40260577 |
| 29 | rRNA methylation (GO:0031167) | 4.29066278 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 4.25173925 |
| 31 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.12282879 |
| 32 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.12282879 |
| 33 | regulation of translation in response to stress (GO:0043555) | 4.09636673 |
| 34 | histone H4-K5 acetylation (GO:0043981) | 4.09489755 |
| 35 | histone H4-K8 acetylation (GO:0043982) | 4.09489755 |
| 36 | histone H4-K12 acetylation (GO:0043983) | 4.09111291 |
| 37 | rRNA modification (GO:0000154) | 4.08807996 |
| 38 | GDP-mannose metabolic process (GO:0019673) | 4.04788127 |
| 39 | negative regulation of cell killing (GO:0031342) | 4.00230101 |
| 40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.00230101 |
| 41 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.99131912 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 3.98078671 |
| 43 | mitotic sister chromatid segregation (GO:0000070) | 3.97078152 |
| 44 | thymic T cell selection (GO:0045061) | 3.92525005 |
| 45 | detection of bacterium (GO:0016045) | 3.92403470 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90608006 |
| 47 | response to muramyl dipeptide (GO:0032495) | 3.89422009 |
| 48 | negative thymic T cell selection (GO:0045060) | 3.88921334 |
| 49 | histone H4 deacetylation (GO:0070933) | 3.85423914 |
| 50 | quinone metabolic process (GO:1901661) | 3.85000494 |
| 51 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.82931411 |
| 52 | heterochromatin organization (GO:0070828) | 3.82438427 |
| 53 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.81103018 |
| 54 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.75346193 |
| 55 | positive regulation of B cell differentiation (GO:0045579) | 3.74690595 |
| 56 | nucleoside transmembrane transport (GO:1901642) | 3.73533249 |
| 57 | DNA replication checkpoint (GO:0000076) | 3.71585791 |
| 58 | primitive streak formation (GO:0090009) | 3.67462472 |
| 59 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.66766455 |
| 60 | detection of other organism (GO:0098543) | 3.66471611 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 3.66012413 |
| 62 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.65003747 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.64962787 |
| 64 | B cell receptor signaling pathway (GO:0050853) | 3.63852277 |
| 65 | maintenance of protein localization in organelle (GO:0072595) | 3.61910025 |
| 66 | response to dietary excess (GO:0002021) | 3.61697217 |
| 67 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.61372100 |
| 68 | cullin deneddylation (GO:0010388) | 3.61037545 |
| 69 | cytidine metabolic process (GO:0046087) | 3.58088810 |
| 70 | cytidine catabolic process (GO:0006216) | 3.58088810 |
| 71 | cytidine deamination (GO:0009972) | 3.58088810 |
| 72 | primary alcohol catabolic process (GO:0034310) | 3.56517973 |
| 73 | epoxygenase P450 pathway (GO:0019373) | 3.56236958 |
| 74 | regulation of cilium movement (GO:0003352) | 3.55913462 |
| 75 | negative regulation of telomere maintenance (GO:0032205) | 3.55613558 |
| 76 | regulation of ARF GTPase activity (GO:0032312) | 3.54821480 |
| 77 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54498065 |
| 78 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.53821184 |
| 79 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52125839 |
| 80 | negative T cell selection (GO:0043383) | 3.51982617 |
| 81 | T cell selection (GO:0045058) | 3.50797798 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 3.47732340 |
| 83 | phenol-containing compound catabolic process (GO:0019336) | 3.45754952 |
| 84 | histone H3 deacetylation (GO:0070932) | 3.44980538 |
| 85 | maternal placenta development (GO:0001893) | 3.42953234 |
| 86 | notochord development (GO:0030903) | 3.41667492 |
| 87 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.38488425 |
| 88 | positive regulation of granulocyte differentiation (GO:0030854) | 3.36793832 |
| 89 | chromatin assembly (GO:0031497) | 3.35518105 |
| 90 | protein deneddylation (GO:0000338) | 3.33195749 |
| 91 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27702411 |
| 92 | sister chromatid segregation (GO:0000819) | 3.25849577 |
| 93 | ribosome biogenesis (GO:0042254) | 3.22940768 |
| 94 | positive T cell selection (GO:0043368) | 3.22147772 |
| 95 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19481432 |
| 96 | interferon-gamma production (GO:0032609) | 3.18518937 |
| 97 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.16713298 |
| 98 | Peyers patch development (GO:0048541) | 3.16713298 |
| 99 | transcription from mitochondrial promoter (GO:0006390) | 3.15373991 |
| 100 | cofactor transport (GO:0051181) | 3.14225393 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13669750 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13669750 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 3.13669750 |
| 104 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13669750 |
| 105 | modulation by symbiont of host defense response (GO:0052031) | 3.13669750 |
| 106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13669750 |
| 107 | ribosomal small subunit biogenesis (GO:0042274) | 3.11731647 |
| 108 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.09914775 |
| 109 | biotin metabolic process (GO:0006768) | 3.09573299 |
| 110 | heme transport (GO:0015886) | 3.07741618 |
| 111 | intestinal epithelial cell development (GO:0060576) | 3.06445462 |
| 112 | response to peptidoglycan (GO:0032494) | 3.06300878 |
| 113 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.05440312 |
| 114 | regulation of B cell differentiation (GO:0045577) | 3.05218838 |
| 115 | cofactor catabolic process (GO:0051187) | 3.04240158 |
| 116 | valine metabolic process (GO:0006573) | 3.03043932 |
| 117 | histone H3-K9 demethylation (GO:0033169) | 3.02405140 |
| 118 | regulation of antigen processing and presentation (GO:0002577) | 3.01310627 |
| 119 | pseudouridine synthesis (GO:0001522) | 3.01228963 |
| 120 | regulation of granulocyte differentiation (GO:0030852) | 3.00026220 |
| 121 | nuclear pore complex assembly (GO:0051292) | 2.99358086 |
| 122 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99245972 |
| 123 | L-ascorbic acid metabolic process (GO:0019852) | 2.95734332 |
| 124 | positive regulation of protein deacetylation (GO:0090312) | 2.95413827 |
| 125 | response to type I interferon (GO:0034340) | 2.92880514 |
| 126 | DNA damage response, detection of DNA damage (GO:0042769) | 2.92064621 |
| 127 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.91528790 |
| 128 | regulation of gene silencing by miRNA (GO:0060964) | 2.91528790 |
| 129 | regulation of gene silencing by RNA (GO:0060966) | 2.91528790 |
| 130 | germinal center formation (GO:0002467) | 2.90456529 |
| 131 | type I interferon signaling pathway (GO:0060337) | 2.89885640 |
| 132 | cellular response to type I interferon (GO:0071357) | 2.89885640 |
| 133 | regulation of telomerase activity (GO:0051972) | 2.88258418 |
| 134 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.87245043 |
| 135 | L-phenylalanine metabolic process (GO:0006558) | 2.87245043 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86667003 |
| 137 | DNA unwinding involved in DNA replication (GO:0006268) | 2.86564161 |
| 138 | DNA duplex unwinding (GO:0032508) | 2.86410042 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.86082545 |
| 140 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85804774 |
| 141 | regulation of histone H3-K27 methylation (GO:0061085) | 2.85058205 |
| 142 | nuclear pore organization (GO:0006999) | 2.84948369 |
| 143 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83908213 |
| 144 | glycine metabolic process (GO:0006544) | 2.82697673 |
| 145 | DNA geometric change (GO:0032392) | 2.82539049 |
| 146 | retinoic acid receptor signaling pathway (GO:0048384) | 2.82438202 |
| 147 | histone H4-K16 acetylation (GO:0043984) | 2.81307782 |
| 148 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.81287773 |
| 149 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.80505438 |
| 150 | mitochondrial DNA replication (GO:0006264) | 2.79278199 |
| 151 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.78846906 |
| 152 | branched-chain amino acid catabolic process (GO:0009083) | 2.78272161 |
| 153 | detection of external biotic stimulus (GO:0098581) | 2.77963823 |
| 154 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.76565941 |
| 155 | drug metabolic process (GO:0017144) | 2.74925171 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.74709294 |
| 157 | cardiovascular system development (GO:0072358) | 2.73707478 |
| 158 | leukocyte aggregation (GO:0070486) | 2.73528684 |
| 159 | NIK/NF-kappaB signaling (GO:0038061) | 2.73469454 |
| 160 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72301211 |
| 161 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72168489 |
| 162 | histone H3-K36 demethylation (GO:0070544) | 2.71770762 |
| 163 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.71678422 |
| 164 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.71539651 |
| 165 | actin nucleation (GO:0045010) | 2.69699940 |
| 166 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.67385418 |
| 167 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.67146102 |
| 168 | positive regulation of histone deacetylation (GO:0031065) | 2.66176540 |
| 169 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.64485936 |
| 170 | mitochondrial DNA metabolic process (GO:0032042) | 2.63706978 |
| 171 | mitotic chromosome condensation (GO:0007076) | 2.62533992 |
| 172 | retrograde transport, endosome to Golgi (GO:0042147) | 2.62430472 |
| 173 | histone H3-K9 modification (GO:0061647) | 2.62392629 |
| 174 | negative regulation of innate immune response (GO:0045824) | 2.61435454 |
| 175 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.60922377 |
| 176 | T cell migration (GO:0072678) | 2.59736453 |
| 177 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.59500693 |
| 178 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.59115939 |
| 179 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.58680594 |
| 180 | macrophage activation involved in immune response (GO:0002281) | 2.58287714 |
| 181 | stress granule assembly (GO:0034063) | 2.56778727 |
| 182 | regulation of leukocyte degranulation (GO:0043300) | 2.56083982 |
| 183 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.54860426 |
| 184 | negative regulation of granulocyte differentiation (GO:0030853) | 2.52710797 |
| 185 | interferon-gamma secretion (GO:0072643) | 2.52346221 |
| 186 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.51822269 |
| 187 | detection of biotic stimulus (GO:0009595) | 2.51620655 |
| 188 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.49984324 |
| 189 | defense response to protozoan (GO:0042832) | 2.48372333 |
| 190 | negative regulation of cell size (GO:0045792) | 2.47815068 |
| 191 | regulation of ARF protein signal transduction (GO:0032012) | 2.45409346 |
| 192 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.44696389 |
| 193 | regulation of monocyte differentiation (GO:0045655) | 2.44614541 |
| 194 | regulation of beta-amyloid formation (GO:1902003) | 2.43220510 |
| 195 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.42918810 |
| 196 | regulation of superoxide anion generation (GO:0032928) | 2.42570892 |
| 197 | B cell mediated immunity (GO:0019724) | 2.42442200 |
| 198 | negative regulation of myotube differentiation (GO:0010832) | 2.42285666 |
| 199 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.42162335 |
| 200 | negative regulation of bone resorption (GO:0045779) | 2.41288841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 4.64074766 |
| 2 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 4.64074766 |
| 3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 4.64074766 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.56128123 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.31960422 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73353841 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.34757501 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.12380682 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.02211858 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.70099340 |
| 11 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.59738826 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.55048234 |
| 13 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.53707816 |
| 14 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.42182377 |
| 15 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.36027006 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.31127402 |
| 17 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.25162682 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14207931 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.13985663 |
| 20 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.12415945 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.10089381 |
| 22 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09340544 |
| 23 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.07711494 |
| 24 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.06776707 |
| 25 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.05614629 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02418870 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98920569 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.98442136 |
| 29 | P68_20966046_ChIP-Seq_HELA_Human | 1.97759337 |
| 30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97440322 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.96808995 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.96768111 |
| 33 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.96697221 |
| 34 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.95731492 |
| 35 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.95297406 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95175767 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.93531616 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.92429742 |
| 39 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.92353838 |
| 40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.92074770 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.91385023 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91060064 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88212252 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82936357 |
| 45 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81939780 |
| 46 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.81090402 |
| 47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.80910547 |
| 48 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.78941303 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.78490048 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76057254 |
| 51 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.75274258 |
| 52 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.74762159 |
| 53 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.74549821 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.73148023 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72649785 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71423770 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67896200 |
| 58 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.67453087 |
| 59 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.67020350 |
| 60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66116159 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.64954979 |
| 62 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.64575300 |
| 63 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.63143353 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.62470922 |
| 65 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.61755371 |
| 66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59049334 |
| 67 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.58782367 |
| 68 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58244033 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.55531349 |
| 70 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52214593 |
| 71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51680650 |
| 72 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51652271 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51334652 |
| 74 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.50455792 |
| 75 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.50115061 |
| 76 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.48919804 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47957265 |
| 78 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46210704 |
| 79 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.44903322 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.43918829 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 1.43809516 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43275583 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43006260 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41670363 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40299667 |
| 86 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.40004141 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39013465 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39004938 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38311125 |
| 90 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.38169973 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36733126 |
| 92 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35689609 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34782021 |
| 94 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.34061475 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32809384 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.32505407 |
| 97 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.32490358 |
| 98 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32215348 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31505231 |
| 100 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.31093401 |
| 101 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30882963 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.29548806 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29283312 |
| 104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28275452 |
| 105 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28122408 |
| 106 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27735189 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.26800701 |
| 108 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.26710577 |
| 109 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25808496 |
| 110 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.24786041 |
| 111 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24660808 |
| 112 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.24590630 |
| 113 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24199312 |
| 114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23883294 |
| 115 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.23864495 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 1.23507180 |
| 117 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.22888446 |
| 118 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.21709703 |
| 119 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.20685455 |
| 120 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.20088680 |
| 121 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.19336935 |
| 122 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19016368 |
| 123 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.18522636 |
| 124 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.17898546 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17795445 |
| 126 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.17610663 |
| 127 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.17531715 |
| 128 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17440440 |
| 129 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.17256493 |
| 130 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16835772 |
| 131 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16536847 |
| 132 | * MYB_26560356_Chip-Seq_TH2_Human | 1.16381813 |
| 133 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.16332648 |
| 134 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.16228759 |
| 135 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15859041 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15609164 |
| 137 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13849921 |
| 138 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13462159 |
| 139 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13238267 |
| 140 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13173269 |
| 141 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12962872 |
| 142 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.12899475 |
| 143 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12807427 |
| 144 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.12640342 |
| 145 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12406907 |
| 146 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11448310 |
| 147 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10813594 |
| 148 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09458491 |
| 149 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.08880767 |
| 150 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08507781 |
| 151 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06318325 |
| 152 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.06192023 |
| 153 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05952640 |
| 154 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.05612030 |
| 155 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.05152811 |
| 156 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04943129 |
| 157 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03320493 |
| 158 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02752032 |
| 159 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02052634 |
| 160 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.01479281 |
| 161 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99976224 |
| 162 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.99669005 |
| 163 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98144542 |
| 164 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98050920 |
| 165 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.97632007 |
| 166 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96040338 |
| 167 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95759602 |
| 168 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.95165318 |
| 169 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93764868 |
| 170 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93151674 |
| 171 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.92742958 |
| 172 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91935750 |
| 173 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90921269 |
| 174 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.89986624 |
| 175 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88040036 |
| 176 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.87291480 |
| 177 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86571093 |
| 178 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86451192 |
| 179 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.85711853 |
| 180 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85525979 |
| 181 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.84765622 |
| 182 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.84453249 |
| 183 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.83548884 |
| 184 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.83542884 |
| 185 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.83181208 |
| 186 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82962400 |
| 187 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82706376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 4.33055962 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 4.30032571 |
| 3 | MP0003436_decreased_susceptibility_to | 4.01868586 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.97524025 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.86131580 |
| 6 | MP0002254_reproductive_system_inflammat | 3.67736454 |
| 7 | MP0006292_abnormal_olfactory_placode | 3.50827070 |
| 8 | MP0001835_abnormal_antigen_presentation | 3.06730432 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 2.99716413 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.96603342 |
| 11 | MP0003890_abnormal_embryonic-extraembry | 2.95549717 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 2.83011458 |
| 13 | MP0009278_abnormal_bone_marrow | 2.76423610 |
| 14 | MP0001800_abnormal_humoral_immune | 2.73468012 |
| 15 | MP0000685_abnormal_immune_system | 2.56502525 |
| 16 | MP0008057_abnormal_DNA_replication | 2.55509127 |
| 17 | MP0005387_immune_system_phenotype | 2.46759416 |
| 18 | MP0001790_abnormal_immune_system | 2.46759416 |
| 19 | MP0005025_abnormal_response_to | 2.44889288 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.38140419 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 2.34931376 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.33402048 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 2.29817990 |
| 24 | MP0006035_abnormal_mitochondrial_morpho | 2.29679872 |
| 25 | MP0003303_peritoneal_inflammation | 2.28530855 |
| 26 | MP0008260_abnormal_autophagy | 2.28429141 |
| 27 | MP0002419_abnormal_innate_immunity | 2.27939928 |
| 28 | MP0005671_abnormal_response_to | 2.26476304 |
| 29 | MP0002723_abnormal_immune_serum | 2.26409911 |
| 30 | MP0005394_taste/olfaction_phenotype | 2.23005186 |
| 31 | MP0005499_abnormal_olfactory_system | 2.23005186 |
| 32 | MP0005365_abnormal_bile_salt | 2.22816981 |
| 33 | MP0002420_abnormal_adaptive_immunity | 2.17077287 |
| 34 | MP0001819_abnormal_immune_cell | 2.15657751 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 2.13775190 |
| 36 | MP0000678_abnormal_parathyroid_gland | 2.12445165 |
| 37 | MP0002452_abnormal_antigen_presenting | 2.11597968 |
| 38 | MP0005360_urolithiasis | 2.06690374 |
| 39 | MP0004858_abnormal_nervous_system | 2.00380513 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.94016068 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.92048986 |
| 42 | MP0002398_abnormal_bone_marrow | 1.88609298 |
| 43 | MP0003724_increased_susceptibility_to | 1.88519887 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.85442475 |
| 45 | MP0000716_abnormal_immune_system | 1.83434483 |
| 46 | MP0005085_abnormal_gallbladder_physiolo | 1.82891215 |
| 47 | MP0002332_abnormal_exercise_endurance | 1.80115613 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.79393965 |
| 49 | MP0003122_maternal_imprinting | 1.78411003 |
| 50 | MP0009785_altered_susceptibility_to | 1.76851726 |
| 51 | MP0002405_respiratory_system_inflammati | 1.72077148 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69133381 |
| 53 | MP0004947_skin_inflammation | 1.67896895 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.65623994 |
| 55 | MP0005380_embryogenesis_phenotype | 1.61820538 |
| 56 | MP0001672_abnormal_embryogenesis/_devel | 1.61820538 |
| 57 | MP0003077_abnormal_cell_cycle | 1.59685561 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.56517926 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.53984136 |
| 60 | MP0002429_abnormal_blood_cell | 1.52815242 |
| 61 | MP0002722_abnormal_immune_system | 1.52764457 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.52085639 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.52073965 |
| 64 | MP0005451_abnormal_body_composition | 1.51685367 |
| 65 | MP0002088_abnormal_embryonic_growth/wei | 1.51411496 |
| 66 | MP0003866_abnormal_defecation | 1.50554268 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.50043629 |
| 68 | MP0003984_embryonic_growth_retardation | 1.49834891 |
| 69 | MP0002148_abnormal_hypersensitivity_rea | 1.48913855 |
| 70 | MP0001873_stomach_inflammation | 1.43536291 |
| 71 | MP0004043_abnormal_pH_regulation | 1.42688423 |
| 72 | MP0005266_abnormal_metabolism | 1.40793811 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.40316199 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.40316199 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.38285884 |
| 76 | MP0003111_abnormal_nucleus_morphology | 1.38181076 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.38179814 |
| 78 | MP0005319_abnormal_enzyme/_coenzyme | 1.35987607 |
| 79 | MP0003690_abnormal_glial_cell | 1.35913764 |
| 80 | MP0010030_abnormal_orbit_morphology | 1.35786860 |
| 81 | MP0003121_genomic_imprinting | 1.35768822 |
| 82 | MP0001853_heart_inflammation | 1.33075256 |
| 83 | MP0001849_ear_inflammation | 1.32568871 |
| 84 | MP0001293_anophthalmia | 1.32245474 |
| 85 | MP0000350_abnormal_cell_proliferation | 1.31925199 |
| 86 | MP0003186_abnormal_redox_activity | 1.29926520 |
| 87 | MP0008469_abnormal_protein_level | 1.27433044 |
| 88 | MP0002933_joint_inflammation | 1.24945807 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 1.22599324 |
| 90 | MP0002092_abnormal_eye_morphology | 1.22151312 |
| 91 | MP0002396_abnormal_hematopoietic_system | 1.20104761 |
| 92 | MP0002970_abnormal_white_adipose | 1.19296206 |
| 93 | MP0002932_abnormal_joint_morphology | 1.18814921 |
| 94 | MP0010094_abnormal_chromosome_stability | 1.18644334 |
| 95 | MP0001986_abnormal_taste_sensitivity | 1.18037519 |
| 96 | MP0000609_abnormal_liver_physiology | 1.17181010 |
| 97 | MP0002086_abnormal_extraembryonic_tissu | 1.16538377 |
| 98 | MP0003252_abnormal_bile_duct | 1.16440866 |
| 99 | MP0006082_CNS_inflammation | 1.15431085 |
| 100 | MP0005076_abnormal_cell_differentiation | 1.13885894 |
| 101 | MP0003329_amyloid_beta_deposits | 1.13691476 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 1.13079619 |
| 103 | MP0004133_heterotaxia | 1.12045963 |
| 104 | MP0009840_abnormal_foam_cell | 1.10749248 |
| 105 | MP0002132_abnormal_respiratory_system | 1.10482280 |
| 106 | MP0001730_embryonic_growth_arrest | 1.08387113 |
| 107 | MP0002085_abnormal_embryonic_tissue | 1.07465050 |
| 108 | MP0005666_abnormal_adipose_tissue | 1.05695016 |
| 109 | MP0003300_gastrointestinal_ulcer | 1.05575168 |
| 110 | MP0003938_abnormal_ear_development | 1.05159438 |
| 111 | MP0000490_abnormal_crypts_of | 1.03211845 |
| 112 | MP0005083_abnormal_biliary_tract | 1.01418511 |
| 113 | MP0004185_abnormal_adipocyte_glucose | 1.00332084 |
| 114 | MP0008007_abnormal_cellular_replicative | 1.00297800 |
| 115 | MP0003123_paternal_imprinting | 0.99817525 |
| 116 | MP0000604_amyloidosis | 0.98776839 |
| 117 | MP0000762_abnormal_tongue_morphology | 0.97708634 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.97283564 |
| 119 | MP0003283_abnormal_digestive_organ | 0.95695845 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.95005397 |
| 121 | MP0008932_abnormal_embryonic_tissue | 0.94698399 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.94472952 |
| 123 | MP0004197_abnormal_fetal_growth/weight/ | 0.93934122 |
| 124 | MP0005332_abnormal_amino_acid | 0.93398181 |
| 125 | MP0002084_abnormal_developmental_patter | 0.92500931 |
| 126 | MP0000313_abnormal_cell_death | 0.91942072 |
| 127 | MP0002080_prenatal_lethality | 0.91925049 |
| 128 | MP0000358_abnormal_cell_content/ | 0.91895272 |
| 129 | MP0000049_abnormal_middle_ear | 0.91478073 |
| 130 | MP0005310_abnormal_salivary_gland | 0.90652154 |
| 131 | MP0001663_abnormal_digestive_system | 0.90378622 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.89664494 |
| 133 | MP0003119_abnormal_digestive_system | 0.89181228 |
| 134 | MP0000598_abnormal_liver_morphology | 0.89063637 |
| 135 | MP0009764_decreased_sensitivity_to | 0.87864611 |
| 136 | MP0001697_abnormal_embryo_size | 0.87831590 |
| 137 | MP0005023_abnormal_wound_healing | 0.87439439 |
| 138 | MP0008789_abnormal_olfactory_epithelium | 0.84845604 |
| 139 | MP0003656_abnormal_erythrocyte_physiolo | 0.84678675 |
| 140 | MP0001666_abnormal_nutrient_absorption | 0.84053184 |
| 141 | MP0002877_abnormal_melanocyte_morpholog | 0.84034353 |
| 142 | MP0004381_abnormal_hair_follicle | 0.83920171 |
| 143 | MP0002138_abnormal_hepatobiliary_system | 0.83179089 |
| 144 | MP0009379_abnormal_foot_pigmentation | 0.82378647 |
| 145 | MP0002233_abnormal_nose_morphology | 0.81691949 |
| 146 | MP0002269_muscular_atrophy | 0.76790972 |
| 147 | MP0002249_abnormal_larynx_morphology | 0.75537060 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.74605183 |
| 149 | MP0002019_abnormal_tumor_incidence | 0.74165413 |
| 150 | MP0001348_abnormal_lacrimal_gland | 0.73917855 |
| 151 | MP0002114_abnormal_axial_skeleton | 0.73065438 |
| 152 | MP0005375_adipose_tissue_phenotype | 0.71958009 |
| 153 | MP0000003_abnormal_adipose_tissue | 0.71336039 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.69897337 |
| 155 | MP0009115_abnormal_fat_cell | 0.69462556 |
| 156 | MP0000428_abnormal_craniofacial_morphol | 0.69368108 |
| 157 | MP0005248_abnormal_Harderian_gland | 0.69306407 |
| 158 | MP0005535_abnormal_body_temperature | 0.68947666 |
| 159 | MP0008058_abnormal_DNA_repair | 0.68685820 |
| 160 | MP0008995_early_reproductive_senescence | 0.68351931 |
| 161 | MP0001764_abnormal_homeostasis | 0.67884808 |
| 162 | MP0009643_abnormal_urine_homeostasis | 0.67752900 |
| 163 | MP0005391_vision/eye_phenotype | 0.65750527 |
| 164 | MP0003191_abnormal_cellular_cholesterol | 0.65733340 |
| 165 | MP0001243_abnormal_dermal_layer | 0.64901461 |
| 166 | MP0000858_altered_metastatic_potential | 0.64837738 |
| 167 | MP0003315_abnormal_perineum_morphology | 0.64698110 |
| 168 | MP0003786_premature_aging | 0.64330200 |
| 169 | MP0000681_abnormal_thyroid_gland | 0.63027848 |
| 170 | MP0000477_abnormal_intestine_morphology | 0.61709254 |
| 171 | MP0002089_abnormal_postnatal_growth/wei | 0.60780958 |
| 172 | MP0005390_skeleton_phenotype | 0.60753360 |
| 173 | MP0002136_abnormal_kidney_physiology | 0.60231606 |
| 174 | MP0002822_catalepsy | 0.59737254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.27501570 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.99642682 |
| 3 | Multiple enchondromatosis (HP:0005701) | 5.79244789 |
| 4 | Hepatoblastoma (HP:0002884) | 4.98376548 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.44917487 |
| 6 | Ependymoma (HP:0002888) | 4.34924232 |
| 7 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.19201836 |
| 8 | Colitis (HP:0002583) | 4.09137635 |
| 9 | Rib fusion (HP:0000902) | 3.97002040 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.90856824 |
| 11 | Panhypogammaglobulinemia (HP:0003139) | 3.84908260 |
| 12 | Agammaglobulinemia (HP:0004432) | 3.82195096 |
| 13 | J-shaped sella turcica (HP:0002680) | 3.77057211 |
| 14 | Ragged-red muscle fibers (HP:0003200) | 3.70595497 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.61759345 |
| 16 | Abnormality of the intrinsic pathway (HP:0010989) | 3.61676173 |
| 17 | Abnormal cartilage morphology (HP:0002763) | 3.58560066 |
| 18 | Rhabdomyosarcoma (HP:0002859) | 3.52989410 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.52509978 |
| 20 | Neoplasm of striated muscle (HP:0009728) | 3.45799410 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27972696 |
| 22 | Recurrent abscess formation (HP:0002722) | 3.26453355 |
| 23 | Increased IgE level (HP:0003212) | 3.22750196 |
| 24 | Myositis (HP:0100614) | 3.20867255 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.18439833 |
| 26 | Testicular atrophy (HP:0000029) | 3.16458574 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13461374 |
| 28 | Obstructive lung disease (HP:0006536) | 3.13461374 |
| 29 | Gastrointestinal inflammation (HP:0004386) | 3.12849700 |
| 30 | Meningitis (HP:0001287) | 3.09579838 |
| 31 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.08350505 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.07787063 |
| 33 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.07451817 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 3.06799012 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 3.03203438 |
| 36 | Trismus (HP:0000211) | 2.97999274 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.97519069 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.97519069 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.96862315 |
| 40 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.92662872 |
| 41 | Hypoplasia of the fovea (HP:0007750) | 2.92662872 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.91947448 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.91947448 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.91947448 |
| 45 | Metaphyseal cupping (HP:0003021) | 2.91944200 |
| 46 | Recurrent viral infections (HP:0004429) | 2.91245516 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.90999511 |
| 48 | Broad face (HP:0000283) | 2.90789610 |
| 49 | Abnormality of the salivary glands (HP:0010286) | 2.89727387 |
| 50 | Partial duplication of thumb phalanx (HP:0009944) | 2.87723478 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.87158508 |
| 52 | Embryonal renal neoplasm (HP:0011794) | 2.83184140 |
| 53 | Aplastic anemia (HP:0001915) | 2.81894426 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80793668 |
| 55 | Progressive muscle weakness (HP:0003323) | 2.80772054 |
| 56 | Hypochromic anemia (HP:0001931) | 2.78075481 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75849252 |
| 58 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75849252 |
| 59 | Hyperglycinuria (HP:0003108) | 2.73580690 |
| 60 | Cellulitis (HP:0100658) | 2.72102526 |
| 61 | Abnormality of the astrocytes (HP:0100707) | 2.70104917 |
| 62 | Astrocytoma (HP:0009592) | 2.70104917 |
| 63 | Fused cervical vertebrae (HP:0002949) | 2.66944984 |
| 64 | Increased cerebral lipofuscin (HP:0011813) | 2.66388256 |
| 65 | Abnormality of lateral ventricle (HP:0030047) | 2.66076263 |
| 66 | Papilledema (HP:0001085) | 2.65029949 |
| 67 | Abnormal lung lobation (HP:0002101) | 2.63757444 |
| 68 | Chromsome breakage (HP:0040012) | 2.63077575 |
| 69 | Type I transferrin isoform profile (HP:0003642) | 2.61183260 |
| 70 | Bifid tongue (HP:0010297) | 2.58566753 |
| 71 | Cervical subluxation (HP:0003308) | 2.58535357 |
| 72 | Malnutrition (HP:0004395) | 2.56380070 |
| 73 | Rectal fistula (HP:0100590) | 2.56126603 |
| 74 | Rectovaginal fistula (HP:0000143) | 2.56126603 |
| 75 | Obstructive sleep apnea (HP:0002870) | 2.55281032 |
| 76 | Seborrheic dermatitis (HP:0001051) | 2.54468624 |
| 77 | Microretrognathia (HP:0000308) | 2.54002701 |
| 78 | Gastrointestinal infarctions (HP:0005244) | 2.51879961 |
| 79 | Partial duplication of the phalanx of hand (HP:0009999) | 2.50650050 |
| 80 | Biconcave vertebral bodies (HP:0004586) | 2.50645232 |
| 81 | Amyotrophic lateral sclerosis (HP:0007354) | 2.50473358 |
| 82 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49472727 |
| 83 | Encephalitis (HP:0002383) | 2.49218319 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.48787441 |
| 85 | Abnormality of the thoracic spine (HP:0100711) | 2.48511847 |
| 86 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.47594504 |
| 87 | Broad distal phalanx of finger (HP:0009836) | 2.45968306 |
| 88 | Thoracic kyphosis (HP:0002942) | 2.45547168 |
| 89 | Vasculitis (HP:0002633) | 2.44808676 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44635028 |
| 91 | Orchitis (HP:0100796) | 2.43536653 |
| 92 | Vaginal fistula (HP:0004320) | 2.43377402 |
| 93 | Pustule (HP:0200039) | 2.42910780 |
| 94 | Impulsivity (HP:0100710) | 2.42075499 |
| 95 | Microvesicular hepatic steatosis (HP:0001414) | 2.40151794 |
| 96 | 3-Methylglutaconic aciduria (HP:0003535) | 2.39092864 |
| 97 | Abnormality of the fingertips (HP:0001211) | 2.35906329 |
| 98 | Recurrent skin infections (HP:0001581) | 2.35771603 |
| 99 | Neurodegeneration (HP:0002180) | 2.35735722 |
| 100 | Gout (HP:0001997) | 2.34591839 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34574662 |
| 102 | Short humerus (HP:0005792) | 2.34168482 |
| 103 | Deep venous thrombosis (HP:0002625) | 2.31218525 |
| 104 | Granulocytopenia (HP:0001913) | 2.29771209 |
| 105 | Hypertensive crisis (HP:0100735) | 2.29234463 |
| 106 | Abnormality of glycolysis (HP:0004366) | 2.29148799 |
| 107 | Increased serum pyruvate (HP:0003542) | 2.29148799 |
| 108 | Preauricular skin tag (HP:0000384) | 2.29109334 |
| 109 | 11 pairs of ribs (HP:0000878) | 2.28577523 |
| 110 | Glomerulonephritis (HP:0000099) | 2.28224195 |
| 111 | Tetraplegia (HP:0002445) | 2.28126353 |
| 112 | Gastrointestinal stroma tumor (HP:0100723) | 2.28025916 |
| 113 | Anomalous pulmonary venous return (HP:0010772) | 2.25425665 |
| 114 | Thin bony cortex (HP:0002753) | 2.23933287 |
| 115 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.23270758 |
| 116 | Villous atrophy (HP:0011473) | 2.23270758 |
| 117 | Intrahepatic cholestasis (HP:0001406) | 2.22978224 |
| 118 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20721780 |
| 119 | Abnormality of glycine metabolism (HP:0010895) | 2.20721780 |
| 120 | Loss of speech (HP:0002371) | 2.19189263 |
| 121 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.18589206 |
| 122 | Hepatosplenomegaly (HP:0001433) | 2.18296983 |
| 123 | Intestinal fistula (HP:0100819) | 2.17637473 |
| 124 | Skin nodule (HP:0200036) | 2.17106739 |
| 125 | Nasal polyposis (HP:0100582) | 2.16383755 |
| 126 | Hyperacusis (HP:0010780) | 2.15600627 |
| 127 | Gingivitis (HP:0000230) | 2.14947427 |
| 128 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.14938929 |
| 129 | Premature ovarian failure (HP:0008209) | 2.14523801 |
| 130 | Optic neuritis (HP:0100653) | 2.14286321 |
| 131 | Retrobulbar optic neuritis (HP:0100654) | 2.14286321 |
| 132 | Recurrent sinusitis (HP:0011108) | 2.13419155 |
| 133 | Abnormality of the peritoneum (HP:0002585) | 2.11488702 |
| 134 | Polygenic inheritance (HP:0010982) | 2.11083225 |
| 135 | Abnormality of the fovea (HP:0000493) | 2.10617770 |
| 136 | Meckel diverticulum (HP:0002245) | 2.09906732 |
| 137 | Pseudobulbar signs (HP:0002200) | 2.08268331 |
| 138 | Hand muscle atrophy (HP:0009130) | 2.08225939 |
| 139 | Abnormality of complement system (HP:0005339) | 2.05887904 |
| 140 | Combined immunodeficiency (HP:0005387) | 2.04894109 |
| 141 | Glossoptosis (HP:0000162) | 2.04628533 |
| 142 | Complement deficiency (HP:0004431) | 2.04456350 |
| 143 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.04260389 |
| 144 | Flattened epiphyses (HP:0003071) | 2.01875083 |
| 145 | Shawl scrotum (HP:0000049) | 2.01342265 |
| 146 | Pulmonary infiltrates (HP:0002113) | 2.01092609 |
| 147 | Upper motor neuron abnormality (HP:0002127) | 2.01000495 |
| 148 | Lymphopenia (HP:0001888) | 2.00366362 |
| 149 | Short 5th finger (HP:0009237) | 1.99901708 |
| 150 | Neuronal loss in central nervous system (HP:0002529) | 1.99327917 |
| 151 | Supernumerary ribs (HP:0005815) | 1.99280131 |
| 152 | Interstitial pulmonary disease (HP:0006530) | 1.98084899 |
| 153 | Missing ribs (HP:0000921) | 1.98069487 |
| 154 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.97118846 |
| 155 | Deformed sella turcica (HP:0002681) | 1.96995420 |
| 156 | Horizontal nystagmus (HP:0000666) | 1.96509844 |
| 157 | Skin tags (HP:0010609) | 1.95842110 |
| 158 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.95578216 |
| 159 | Abnormal gallbladder physiology (HP:0012438) | 1.95400638 |
| 160 | Cholecystitis (HP:0001082) | 1.95400638 |
| 161 | Increased serum ferritin (HP:0003281) | 1.95190786 |
| 162 | Flat acetabular roof (HP:0003180) | 1.95156169 |
| 163 | Glioma (HP:0009733) | 1.95038477 |
| 164 | Abnormality of the ileum (HP:0001549) | 1.94767263 |
| 165 | Medulloblastoma (HP:0002885) | 1.94245391 |
| 166 | Secondary amenorrhea (HP:0000869) | 1.94209468 |
| 167 | Angiofibromas (HP:0010615) | 1.94125326 |
| 168 | Adenoma sebaceum (HP:0009720) | 1.94125326 |
| 169 | Cerebral aneurysm (HP:0004944) | 1.93652505 |
| 170 | Emphysema (HP:0002097) | 1.93154206 |
| 171 | Tongue fasciculations (HP:0001308) | 1.89804995 |
| 172 | Generalized hypotonia (HP:0001290) | 1.89426207 |
| 173 | Prolonged bleeding time (HP:0003010) | 1.88934220 |
| 174 | Hyperammonemia (HP:0001987) | 1.88504058 |
| 175 | Cerebral palsy (HP:0100021) | 1.88104754 |
| 176 | Joint stiffness (HP:0001387) | 1.87735446 |
| 177 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.87217369 |
| 178 | Stridor (HP:0010307) | 1.85741419 |
| 179 | Abnormality of the pulmonary veins (HP:0011718) | 1.85457080 |
| 180 | Supernumerary spleens (HP:0009799) | 1.85365201 |
| 181 | Abnormality of the pleura (HP:0002103) | 1.85082530 |
| 182 | Hypergammaglobulinemia (HP:0010702) | 1.84380669 |
| 183 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.84175559 |
| 184 | Atelectasis (HP:0100750) | 1.84001562 |
| 185 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.82410563 |
| 186 | Purpura (HP:0000979) | 1.81695586 |
| 187 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.81665517 |
| 188 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.81665517 |
| 189 | Abnormality of the nasal mucosa (HP:0000433) | 1.81232426 |
| 190 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80730624 |
| 191 | Abnormality of the musculature of the hand (HP:0001421) | 1.79971005 |
| 192 | Ketoacidosis (HP:0001993) | 1.79655721 |
| 193 | Hypopigmentation of the fundus (HP:0007894) | 1.78852643 |
| 194 | Hyperventilation (HP:0002883) | 1.76995029 |
| 195 | Ketosis (HP:0001946) | 1.76736121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.16270279 |
| 2 | ERN1 | 5.99078414 |
| 3 | GRK5 | 4.34401060 |
| 4 | GRK6 | 4.25121000 |
| 5 | MAP4K1 | 3.36279171 |
| 6 | RIPK4 | 2.97319300 |
| 7 | GRK1 | 2.78792305 |
| 8 | CSF1R | 2.70556326 |
| 9 | ADRBK2 | 2.68055866 |
| 10 | TGFBR2 | 2.49933890 |
| 11 | TTK | 2.49650644 |
| 12 | TYK2 | 2.38880208 |
| 13 | SIK2 | 2.37724513 |
| 14 | MAP2K3 | 2.18828764 |
| 15 | TNK2 | 2.15584684 |
| 16 | STK10 | 2.15212179 |
| 17 | BCKDK | 2.11885290 |
| 18 | PRPF4B | 2.10016878 |
| 19 | TYRO3 | 2.01824564 |
| 20 | MAPK7 | 2.00023961 |
| 21 | MATK | 1.92701122 |
| 22 | MAP3K13 | 1.91473305 |
| 23 | EPHA2 | 1.80468093 |
| 24 | SMG1 | 1.77606309 |
| 25 | GRK7 | 1.77343437 |
| 26 | CDK7 | 1.72381418 |
| 27 | BUB1 | 1.62075524 |
| 28 | FES | 1.56785011 |
| 29 | BTK | 1.56222164 |
| 30 | MOS | 1.54919144 |
| 31 | MAP3K14 | 1.54878611 |
| 32 | TBK1 | 1.54177251 |
| 33 | JAK3 | 1.49116790 |
| 34 | PAK4 | 1.44622939 |
| 35 | TAOK3 | 1.41955699 |
| 36 | PRKG2 | 1.38867230 |
| 37 | TESK2 | 1.36657336 |
| 38 | MAP3K10 | 1.35293670 |
| 39 | PTK6 | 1.29478596 |
| 40 | AKT3 | 1.28201468 |
| 41 | MAP3K6 | 1.27076674 |
| 42 | WNK1 | 1.25784617 |
| 43 | KIT | 1.23515909 |
| 44 | IKBKE | 1.23163968 |
| 45 | MAPK15 | 1.22702244 |
| 46 | CDC42BPA | 1.21796171 |
| 47 | FLT3 | 1.21335109 |
| 48 | CAMK4 | 1.21167359 |
| 49 | SYK | 1.19430602 |
| 50 | PLK1 | 1.18259731 |
| 51 | IRAK4 | 1.17491926 |
| 52 | PRKD2 | 1.16989229 |
| 53 | MAP2K2 | 1.16927838 |
| 54 | CHEK2 | 1.11732895 |
| 55 | NTRK1 | 1.11681058 |
| 56 | SIK3 | 1.11002968 |
| 57 | MAP3K11 | 1.07970876 |
| 58 | WEE1 | 1.07940123 |
| 59 | HIPK2 | 1.04595701 |
| 60 | NEK2 | 1.01737507 |
| 61 | CAMKK1 | 0.98113936 |
| 62 | RPS6KB2 | 0.96630011 |
| 63 | MARK2 | 0.94311024 |
| 64 | MAPK11 | 0.90698819 |
| 65 | LYN | 0.90436134 |
| 66 | PDPK1 | 0.90215990 |
| 67 | PDK1 | 0.89422927 |
| 68 | LCK | 0.88285318 |
| 69 | RIPK1 | 0.87317802 |
| 70 | MAP2K6 | 0.84478604 |
| 71 | HCK | 0.83848900 |
| 72 | ADRBK1 | 0.83410581 |
| 73 | SIK1 | 0.81576793 |
| 74 | RET | 0.79715460 |
| 75 | PRKCI | 0.79135883 |
| 76 | CSK | 0.78329428 |
| 77 | CDC7 | 0.77773466 |
| 78 | JAK2 | 0.77606067 |
| 79 | CHEK1 | 0.77021335 |
| 80 | MAPKAPK3 | 0.75052654 |
| 81 | PASK | 0.71905748 |
| 82 | RPS6KC1 | 0.71826949 |
| 83 | RPS6KL1 | 0.71826949 |
| 84 | JAK1 | 0.70786812 |
| 85 | FGFR3 | 0.70326041 |
| 86 | CDK4 | 0.69915597 |
| 87 | AKT2 | 0.68237787 |
| 88 | NME1 | 0.67414271 |
| 89 | AURKA | 0.67202461 |
| 90 | MAP2K4 | 0.65735982 |
| 91 | DYRK3 | 0.63717726 |
| 92 | MTOR | 0.63055700 |
| 93 | EPHB1 | 0.62204790 |
| 94 | FGR | 0.61507282 |
| 95 | MAP3K7 | 0.61049986 |
| 96 | NTRK2 | 0.60059347 |
| 97 | MARK3 | 0.59939513 |
| 98 | RPS6KA6 | 0.59320377 |
| 99 | MST1R | 0.58185760 |
| 100 | BMX | 0.57841789 |
| 101 | AURKB | 0.56738117 |
| 102 | RPS6KA2 | 0.56141494 |
| 103 | NME2 | 0.55773329 |
| 104 | EIF2AK3 | 0.53534354 |
| 105 | ITK | 0.51213360 |
| 106 | FYN | 0.50831147 |
| 107 | DYRK1A | 0.50721051 |
| 108 | TRIB3 | 0.50588867 |
| 109 | NEK1 | 0.49126496 |
| 110 | ALK | 0.48554616 |
| 111 | PDK2 | 0.48313647 |
| 112 | PRKD3 | 0.48157191 |
| 113 | EIF2AK2 | 0.48140674 |
| 114 | TAOK1 | 0.47253027 |
| 115 | CHUK | 0.46350219 |
| 116 | CDK2 | 0.46076164 |
| 117 | MAPK3 | 0.45869367 |
| 118 | PDGFRA | 0.43903193 |
| 119 | TLK1 | 0.43834450 |
| 120 | FGFR2 | 0.43365229 |
| 121 | MAP3K1 | 0.42784056 |
| 122 | PTK2 | 0.42728320 |
| 123 | STK16 | 0.42528813 |
| 124 | PAK1 | 0.40231535 |
| 125 | PDK4 | 0.39734677 |
| 126 | PDK3 | 0.39734677 |
| 127 | MAPKAPK2 | 0.39557214 |
| 128 | PRKCQ | 0.38680260 |
| 129 | TXK | 0.38247371 |
| 130 | DYRK1B | 0.37827624 |
| 131 | IGF1R | 0.37538293 |
| 132 | MAPK12 | 0.36443690 |
| 133 | SRPK1 | 0.36390302 |
| 134 | FGFR4 | 0.34011884 |
| 135 | ZAP70 | 0.33753821 |
| 136 | PIM2 | 0.33632682 |
| 137 | KDR | 0.32995919 |
| 138 | EEF2K | 0.31915239 |
| 139 | ERBB2 | 0.31801630 |
| 140 | ATM | 0.31135915 |
| 141 | ATR | 0.29016882 |
| 142 | PRKCD | 0.28394424 |
| 143 | PKN2 | 0.25250309 |
| 144 | DYRK2 | 0.25191946 |
| 145 | CSNK1E | 0.25103223 |
| 146 | BLK | 0.24786392 |
| 147 | MET | 0.23730988 |
| 148 | BRSK2 | 0.23499061 |
| 149 | MAP3K8 | 0.22016204 |
| 150 | CDK1 | 0.20689473 |
| 151 | ICK | 0.20655959 |
| 152 | LRRK2 | 0.20348383 |
| 153 | MAP3K3 | 0.19675351 |
| 154 | MAPK4 | 0.19427471 |
| 155 | GSK3A | 0.18470922 |
| 156 | TESK1 | 0.18152800 |
| 157 | EIF2AK1 | 0.17739438 |
| 158 | MAPK1 | 0.17686398 |
| 159 | PIM1 | 0.17620615 |
| 160 | CDK8 | 0.17473746 |
| 161 | IKBKB | 0.16399241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.44915078 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.07116390 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.96355462 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.81882077 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.60274546 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.59548100 |
| 7 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46300733 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.42195861 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.35337381 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.30332977 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24355536 |
| 12 | Galactose metabolism_Homo sapiens_hsa00052 | 2.23574745 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.19879024 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.15049150 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14531158 |
| 16 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.09680792 |
| 17 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.04755220 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.04183047 |
| 19 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.01086992 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.98760755 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96115613 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95558297 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91732996 |
| 24 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.89591391 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.87019097 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.86951227 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82689358 |
| 28 | DNA replication_Homo sapiens_hsa03030 | 1.81176835 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80551786 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79890537 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.72183018 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.68358409 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.66775429 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63856738 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63000127 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.60456088 |
| 37 | Mismatch repair_Homo sapiens_hsa03430 | 1.60008992 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.56280637 |
| 39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.54618268 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50600172 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.49146054 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.48999082 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.48850625 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44847790 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.43382769 |
| 46 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43256956 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.43253863 |
| 48 | RNA transport_Homo sapiens_hsa03013 | 1.41316173 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 1.40989858 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39930176 |
| 51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39501540 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39039774 |
| 53 | Influenza A_Homo sapiens_hsa05164 | 1.37770161 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 1.36554323 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.35261937 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35160032 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.32602344 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.32535171 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.32458486 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31886772 |
| 61 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26080006 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.22743618 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.22676088 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 1.21914274 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.20968691 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20650130 |
| 67 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19275509 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.19235180 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17760521 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 1.12918121 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.12913248 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11763849 |
| 73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10774497 |
| 74 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10766854 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10318506 |
| 76 | Homologous recombination_Homo sapiens_hsa03440 | 1.09629266 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09071835 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.04770538 |
| 79 | Base excision repair_Homo sapiens_hsa03410 | 1.04554042 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04390669 |
| 81 | Measles_Homo sapiens_hsa05162 | 1.03855401 |
| 82 | Spliceosome_Homo sapiens_hsa03040 | 1.01629724 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99683736 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.95847891 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.95111111 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94925131 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94482311 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93468955 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.91924646 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91360685 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91161991 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.90995099 |
| 93 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.90599688 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89636480 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87583615 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.87305991 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.87175446 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86970647 |
| 99 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85792222 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85231106 |
| 101 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83738966 |
| 102 | Pertussis_Homo sapiens_hsa05133 | 0.83134699 |
| 103 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81987356 |
| 104 | Thyroid cancer_Homo sapiens_hsa05216 | 0.80789459 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79966603 |
| 106 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.79949334 |
| 107 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.79417721 |
| 108 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79093178 |
| 109 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.77552092 |
| 110 | RNA polymerase_Homo sapiens_hsa03020 | 0.77419543 |
| 111 | Proteasome_Homo sapiens_hsa03050 | 0.76276187 |
| 112 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75432689 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74612466 |
| 114 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.74191448 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74130789 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73885230 |
| 117 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72421359 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71809224 |
| 119 | Cell cycle_Homo sapiens_hsa04110 | 0.71372171 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71279524 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70802084 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70536472 |
| 123 | Apoptosis_Homo sapiens_hsa04210 | 0.69346659 |
| 124 | RNA degradation_Homo sapiens_hsa03018 | 0.69242360 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.68222440 |
| 126 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66954512 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66809693 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66663804 |
| 129 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65516981 |
| 130 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64727341 |
| 131 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.64157278 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61267118 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61084178 |
| 134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60309912 |
| 135 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60221127 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58587934 |
| 137 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58537588 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57534987 |
| 139 | Insulin resistance_Homo sapiens_hsa04931 | 0.56313299 |
| 140 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54400707 |
| 141 | ABC transporters_Homo sapiens_hsa02010 | 0.54250446 |
| 142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53690118 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53684918 |
| 144 | Lysine degradation_Homo sapiens_hsa00310 | 0.53288741 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52665326 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51992873 |
| 147 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51382946 |
| 148 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51180209 |
| 149 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.50685496 |
| 150 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49772924 |
| 151 | Platelet activation_Homo sapiens_hsa04611 | 0.49201457 |
| 152 | Phagosome_Homo sapiens_hsa04145 | 0.48885193 |
| 153 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.47610128 |
| 154 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47058785 |
| 155 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.46833639 |
| 156 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45889106 |
| 157 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.45476794 |
| 158 | Endocytosis_Homo sapiens_hsa04144 | 0.44431967 |
| 159 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43518524 |
| 160 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43393357 |
| 161 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42104869 |
| 162 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41874185 |
| 163 | Malaria_Homo sapiens_hsa05144 | 0.41586689 |
| 164 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40948617 |
| 165 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.40848043 |
| 166 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40760316 |
| 167 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40263208 |
| 168 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39707190 |
| 169 | Bile secretion_Homo sapiens_hsa04976 | 0.36514702 |
| 170 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35897485 |
| 171 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35692456 |
| 172 | Glioma_Homo sapiens_hsa05214 | 0.34101141 |
| 173 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33480652 |
| 174 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.33159379 |
| 175 | Bladder cancer_Homo sapiens_hsa05219 | 0.32605792 |
| 176 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32230389 |
| 177 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31499990 |
| 178 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31039987 |
| 179 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.28548982 |
| 180 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28394586 |
| 181 | Shigellosis_Homo sapiens_hsa05131 | 0.27879757 |
| 182 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26151406 |

